• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Directories » Research Center Profiles » Alliance for Multispecialty Research – Utah (formerly Pharmaceutical Research Organization)

AND
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • R
  • S
  • T
  • U
  • V
  • W

Alliance for Multispecialty Research – Utah (formerly Pharmaceutical Research Organization)

  • Profile
  • Contact Center or Provider

Profile

AMR Utah Logo new

Contact Information

Contact: Nancy J. Cleverley, Executive Director
Phone: 801-294-9911
Fax: 801-294-9922
Email: Click here to see email.
Website: http://www.pharmaceuticalresearchorganization.com/

Center Information

Nancy J. Cleverley
General Manager
Alliance for Multispecialty Research – Utah (formerly Pharmaceutical Research Organization)
1596 South 500 West, 2nd Floor
Bountiful, UT 84010
801.294.9911
Fax: 801.294.9922
nancy.cleverley@amrllc.com
www.amrutah.com

Currently Enrolling Trials

    Show More

    Overview

    AMR Utah, a trial management organization, offers a diverse arena of clinical trial capabilities including pediatric and adult outpatient and inpatient studies. We pride ourselves in delivering timely, accurate and reproducible results to sponsor companies and clinical research organizations. We insist on producing work of only the highest caliber. Sponsors and CROs can reach our administrative officers or any of our trained study coordinators 24 hours a day, seven days a week. Our goal is to make the entire clinical trial process smooth from beginning to end by placement, principal investigator recruitment and training, contract and budget negotiation, regulatory affairs, coordinator assignments, patient recruitment, data collection, quality assurance and compliance.

    Mission Statement

    Building a healthier future, one clinical trial at a time.

    Values

    Humility

    Integrity

    Professionalism

    Accuracy

    Respect

    Philosophy

    AMR Utah’s philosophy is to improve healthcare locally and globally by managing clinical trials in a prompt, efficient manner and to the highest quality standards.

    We treat our customers — pharmaceutical companies, CROs, investigators and their clinic staff and patients — as well as our employees, with the utmost respect and professionalism.

    We provide the best possible experience for our customers during the clinical trial process and accept no excuses for less than outstanding service and resolution to all issues — predicted or unforeseen.

    Research Experience

    AMR Utah has established relationships with a wide range of specialty practices. We will also recruit additional principal investigators and sites for almost any specialty or practice to meet sponsor requirements or protocol-specific needs, as well as place trained and research-dedicated study coordinators at those sites.

    AMR Utah conducts mainly phase 2 to 4 clinical research protocols. For a more detailed listing of our clinical research experience, please visit our web page, www.amrutah.com.

    Sponsors and CROs AMR Utah has contracted with include:

    Sponsors

    • 3M Pharmaceuticals
    • Accelovance
    • Access Pharmaceuticals
    • Advancis Pharmaceutical
    • Alcon Research
    • Altana
    • Amgen
    • AstraZeneca
    • Astellas
    • Astellas Scientific and Medical Affairs
    • Aventis Pasteur
    • Bayer Consumer Care
    • Bayer Pharmaceuticals
    • BioSante Pharmaceuticals
    • Boehringer Ingelheim Pharmaceuticals
    • Bristol Myers Squibb
    • Celltech Pharmaceuticals
    • Dow Pharmaceutical Sciences
    • Eli Lilly and Company/Reliant Pharmaceuticals
    • Ferndale Laboratories
    • Forest Laboratories
    • G.D. Searle
    • Genomics Collaborative
    • GlaxoSmithKline Biologicals
    • GlaxoSmithKline Group of Companies
    • GlaxoWellcome
    • Guilford Pharmaceuticals
    • Hatchtech
    • IBSA
    • InSite Vision
    • Janssen Pharmaceutical
    • KV Pharmaceutical
    • Labopharm
    • Luitpold Pharmaceuticals
    • MannKind
    • MedImmune Vaccines
    • Medivector
    • Merck
    • Merck KGaA
    • Mesa Biotech
    • Myriad Pharmaceuticals
    • Novartis Pharmaceuticals
    • Novan
    • OrthoBiotech Products
    • OrthoLogic
    • Osel
    • Otsuka Maryland Research Institute
    • Perlegen Sciences
    • Pfizer
    • Pharmacia
    • Sandoz
    • Sanofi Pasteur
    • Schering-Plough Research Institute
    • SeraCare Life Sciences
    • Shionogi
    • Shire Pharmaceuticals Group
    • SmithKline Beecham
    • Solvay Pharmaceuticals
    • Spear Pharmaceuticals
    • Sucampo
    • TEVA Pharmaceuticals USA
    • Vertex Pharmaceuticals
    • Watson Laboratories

    CROs

    • AAI Development Services
    • B & B Clinical Innovations
    • CareStat
    • Chiltern International
    • Clinical Research Group
    • Clinical Trials Management Services
    • Covalent Group
    • Covance
    • i3 Research
    • Icon Clinical Research
    • Ingenix Pharmaceutical Services
    • Integrium
    • Inveresk
    • Kendle International
    • Monitoring Force
    • Norwich Clinical Research
      Associates
    • Omnicare
    • Ovation Research Group
    • Parexel International Corporation
    • PharmaNet
    • The Phoenix
    • PPD Development
    • PRA International
    • Premier Research
    • Quintiles
    • ReSearch Pharmaceutical Services,
    • ResearchPoint
    • Research Scientists
    • SCIREX
    • SFBC Charlotte
    • SFBC New Drug Services
    • Synteract
    • Therapeutics

    Clinical trial research experience by drug category

    • Analgesic
    • Antibiotic
    • Antihistamine
    • Anti-inflammatory
    • Asthma
    • Bacterio therapeutic
    • Blood conservation
    • Bone growth stimulator
    • Bronchodilator
    • Calcimimetic agent
    • Central nervous system stimulant
      (extended release)
    • Chloride channel activator
    • Conscious sedation
    • Contraceptive–injectable
    • COVID-19 vaccine
    • Hematinic
    • Histamine H2–receptor antagonist
    • Hormone replacement therapy - male
    • Hormone replacement therapy - female
    • IgE binder
    • Immune response modifier
    • Inhaled corticosteroid
    • Intraocular pressure-lowering agent
    • Leukotriene receptor antagonist
    • Lipid-lowering agent
    • Long-acting beta–adrenergic agonist
    • Mucoadhesive patch
    • Ocular antibiotic/steroid
    • Ocular antibiotic
    • Ocular hypotensive
    • Ocular steroid
    • Oral corticosteroid
    • Pain research
    • Pediculocide
    • Plasmapheresis
    • Quinolone antibiotic
    • Red blood cell production stimulant
    • Respiratory syncytial virus
    • Serotonin receptor agonist
    • Statin
    • Synthetic inhaled corticosteroid
    • Testosterone gel
    • Topical antibiotic
    • Topical corticosteroid
    • Topical hormone gel
    • Topical steroid
    • Triptan
    • Vaccine–concomitantly administered
    • Vaccine–miscellaneous combinations
    • Vaccine–pentavalent combinations
    • Vaccine–quadravalent combinations
    • Vaccine–rotavirus
    • Vaccine–tetravalent combinations
    • Vaccine–seasonal and H1N1 influenza

    To date, AMR Utah has contracted with 90 pharmaceutical companies, 50 contract research organizations, more than 47 independent and private-practice principal investigators, and 30-plus investigative sites to conduct 450 research studies and enroll more than 16,000 patients throughout the states of Utah and Idaho.

    Investigator Experience

    Investigative sites include, but are not limited to, the following areas of specialty:

    • Audiology
    • Dentistry
    • Dermatology
    • Family practice
    • Gastroenterology
    • Geriatrics
    • Hematology
    • Internal medicine
    • Immunology/infectious disease
    • Nephrology
    • Neurology
    • Obstetrics and gynecology
    • Ophthalmology
    • Optometry
    • Orthopedics
    • Otolaryngology
    • Pediatrics
    • Pharmacology
    • Public Health
    • Sports Medicine
    • Surgery

    Staff Expertise

    AMR Utah is comprised of trained coordinators with more than 40 years combined coordinator research experience.

    A special note about our clinical research coordinators: Our coordinators are research-dedicated. They consist of mostly full-time and a few part-time employees. Their backgrounds include RN, LPN or CMA degrees as well as ACRP and SOCRA certifications. These research-trained and dedicated coordinators are placed at our investigational sites to assist the investigators in recruiting, screening, enrolling and gathering data on each of our contracted protocols to help ensure GCP/ICH compliance and high, quality enrollment.

    Patient Demographics

    Composition by race (site dependent):

    Caucasian  - 80 percent
    African-American – 5 percent
    Asian - 5 percent
    Hispanic – 5 percent
    Other – 5 percent

    Composition by gender:

    Male 50 percent
    Female 50 percent

    Other Information

    AMR Utah uses a central IRB.

    Contact Center or Provider

    Back to Listings

    Upcoming Events

    • 06Jun

      Gene & Cell Therapy Regulation: Comparability and Other New Developments

    • 07Jun

      Developing World-Class SOPs: Optimizing Quality and Compliance

    • 08Jun

      Implementing ICH E8 R1 Recommendations Increases Site and Participant Relationship Scoring Measures

    Featured Products

    • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

      Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    Featured Stories

    • MAGI East 2023

      MAGI East 2023 Preview: Janssen Reports on Environmental Impact of Trials

    • Complexity-360x240.png

      Phase 3 Trials Significantly Rising in Complexity, Says CSDD

    • Quality Level Scale

      Build Quality into Trials Like You’d Build a House, Says FDA’s BIMO Director

    • DE&I

      Trust-Building, Community Connection Still Essential to DE&I Efforts, Experts Say

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing